Data Year:

For its 2025 fiscal year, UNITEDHEALTH GROUP INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In Insurance industry
Stephen J. Hemsley
Chief Executive Officer, Director
Total Compensation $60,938,062 View details Pay Rank By Title In Insurance industry #5 View more
Andrew Witty
Former Chief Executive Officer
Total Compensation $24,599,372 View details Pay Rank By Title In Insurance industry #12 View more
John Rex
Former President and Chief Financial Officer
Total Compensation $24,475,981 View details Pay Rank By Title In Insurance industry #2 View more
Christopher Zaetta
Executive Vice President Chief Legal Officer and Corporate Secretary
Total Compensation $15,792,307 View details Pay Rank By Title In Insurance industry #1 View more
Patrick Conway M.D.
Chief Executive Officer, Optum
Total Compensation $19,922,610 View details Pay Rank By Title In Insurance industry #21 View more
Wayne DeVeydt
Chief Financial Officer
Total Compensation $14,582,684 View details Pay Rank By Title In Insurance industry #6 View more
Timothy Noel
Chief Executive Officer, UnitedHealthcare
Total Compensation $20,201,746 View details Pay Rank By Title In Insurance industry #20 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at UNITEDHEALTH GROUP INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. UNITEDHEALTH GROUP INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. UNITEDHEALTH GROUP INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Stephen J. Hemsley
Chief Executive Officer, Director
Total Cash $596,154 Equity $60,000,024 Other $341,884 $60,938,062
Andrew Witty
Former Chief Executive Officer
Total Cash $903,846 Equity $23,000,639 Other $694,887 $24,599,372
John Rex
Former President and Chief Financial Officer
Total Cash $1,400,000 Equity $15,000,277 Other $8,075,704 $24,475,981
Christopher Zaetta
Executive Vice President Chief Legal Officer and Corporate Secretary
Total Cash $1,770,192 Equity $14,000,845 Other $21,270 $15,792,307
Patrick Conway M.D.
Chief Executive Officer, Optum
Total Cash $2,730,577 Equity $17,001,005 Other $191,028 $19,922,610
Wayne DeVeydt
Chief Financial Officer
Total Cash $2,984,615 Equity $11,500,475 Other $97,594 $14,582,684
Timothy Noel
Chief Executive Officer, UnitedHealthcare
Total Cash $2,731,827 Equity $17,000,585 Other $469,334 $20,201,746
For its 2025 fiscal year, UNITEDHEALTH GROUP INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Stephen J. Hemsley CEO Pay $60,950,571 Median Employee Pay $81,474 CEO Pay Ratio 748:1
For its 2025 fiscal year, UNITEDHEALTH GROUP INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Charles Baker Total Cash $375,029
F. William McNabb, III Total Cash $409,446
John Noseworthy, M.D. Total Cash $381,797
Kristen Gil Total Cash $575,514
Michele Hooper Total Cash $423,212
Paul Garcia Total Cash $375,366
Scott Gottlieb, M.D. Total Cash $42,050
Stephen Hemsley Total Cash $211,889
Timothy Flynn Total Cash $404,439
Valerie C. Montgomery Rice, M.D. Total Cash $390,987
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.